Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-23T23:08:42.516Z Has data issue: false hasContentIssue false

32 - Central nervous system

Published online by Cambridge University Press:  23 December 2009

Sean Elyan
Affiliation:
Consultant, Clinical Oncologist, Cheltenham General Hospital, Cheltenham, UK
Louise Hanna
Affiliation:
Velindre Hospital, Cardiff
Tom Crosby
Affiliation:
Velindre Hospital, Cardiff
Fergus Macbeth
Affiliation:
Velindre Hospital, Cardiff
Get access

Summary

Introduction

This chapter describes the management of tumours in adults in the following anatomical areas: cerebral convexity and cerebral hemispheres, the skull base, the pituitary, the pineal region and the spinal cord.

Central nervous system (CNS) tumours are heterogeneous. The terms malignant and benign are not very useful because:

  • Even small slowly growing tumours can cause severe symptoms because the brain is enclosed in a rigid skull.

  • Surgery can be difficult because many tumours are infiltrating and often lie close to critical structures.

  • Most of these tumours rarely, if ever, metastasise outside the CNS.

  • Slow-growing tumours may transform into a much more aggressive variant.

This chapter does not deal with metastatic disease to the CNS that is considered in other relevant chapters, although management of cerebral metastases that require specialist neuro-oncology input is discussed briefly. CNS tumours in children are considered in Chapter 37 (see p. 432).

Anatomy

The tentorium separates the supratentorial from the infratentorial areas of the brain. The motor and sensory cortices lie at the central sulcus. Broca's area (frontal, above the lateral sulcus) is responsible for expressive loss of speech, and Wernicke's area (temporal, posterior end of the lateral sulcus) is responsible for receptive loss of speech. The ventricular system is lined with ependyma. CSF travels from the third to the fourth ventricle through the cerebral aqueduct and from the fourth ventricle to the subarachnoid space through the foramina of Magendie (median) and Luschka (lateral).

The anterior and intermediate lobes of the pituitary arise from Rathke's pouch.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beral, V., Peterman, T., Berkelman, R.et al. (1991). aquired immune deficiency syndrome-associated non-Hodgkin lymphoma. Lancet, 337, 805–9.CrossRefGoogle Scholar
Bleehen, N. M. and Stenning, S. P. (1991). A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br. J. Cancer, 64, 769–74.CrossRefGoogle ScholarPubMed
Bliss, P., Kerr, G. R. and Gregor, A. (1994). Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962–1990. Clin. Oncol. (R. Coll. Radiol.), 6, 361–3.CrossRefGoogle ScholarPubMed
Brandes, A. A., Ermani, M., Amista, P.et al. (2003). The treatment of adults with medulloblastoma: a prospective study. Int. J. Radiat. Oncol. Biol. Phys, 57, 755–61.CrossRefGoogle ScholarPubMed
Cairncross, J. G., Ueki, K., Zlatescu, M. C.et al. (1998). Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst., 90, 1473–9.CrossRefGoogle ScholarPubMed
Ford, J. M., Stenning, S. P., Boote, D. J.et al. (1997). A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin. Oncol. (R. Coll. Radiol.), 9, 20–4.CrossRefGoogle Scholar
Kleihues, P. and Cavenee, W. K. (2000). Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press.Google Scholar
Laperriere, N., Zuraw, L. and Cairncross, G. (2002). Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother. Oncol., 64, 259–73.CrossRefGoogle Scholar
Laurent, J. P., Chang, C. H. and Cohen, M. E. (1985). A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer, 56, 1807–9.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Mondok, A., Szeifert, G. T., Mayer, A.et al. (2005). Treatment of pituitary tumors: radiation. Endocrine, 28, 77–85.CrossRefGoogle ScholarPubMed
Patchell, R. A., Tibbs, P. A., Walsh, J. W.et al. (1990). A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med., 322, 494–500.CrossRefGoogle Scholar
Patchell, R. A., Tibbs, P. A., Regine, W. F.et al. (1998). Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. J. A. M. A., 280, 1485–9.CrossRefGoogle ScholarPubMed
Pignatti, F., Bent, M., Curran, D.et al. (2002). Prognostic factors for survival in adult patients with cerebral low-grade glioma. J. Clin. Oncol., 20, 2076–84.CrossRefGoogle ScholarPubMed
Pobereskin, L. H. and Chadduck, J. B. (2000). Incidence of brain tumours in two English counties: a population based study. J. Neurol. Neurosurg. Psychiatry, 69, 464–71.CrossRefGoogle ScholarPubMed
Stewart, L. A. (2002). Chemotherapy in adult high grade glioma: a systemic review and meta-analysis of individual patient data from 12 randomised trials. Lancet, 359, 1011–18.Google ScholarPubMed
Stupp, R., Mason, W. P., Bent, M. J.et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 352, 987–96.CrossRefGoogle ScholarPubMed
Bent, M., Chinot, O. L. and Cairncross, J. G. (2003). Recent developments in the molecular characterization and treatment of oligodendroglial tumors. Neuro. Oncol., 5, 128–38.CrossRefGoogle ScholarPubMed
Bent, M. J., Afra, D., Witte, O.et al. (2005). Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the European Organisation for Research and Treatment of Cancer 22845 randomised trial. Lancet, 366, 985–90.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×